
NeoGenomics NEO
$ 12.69
-0.78%
Quarterly report 2025-Q2
added 07-29-2025
NeoGenomics Shares 2011-2026 | NEO
Annual Shares NeoGenomics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127 M | 126 M | 124 M | 120 M | 109 M | 100 M | 85.6 M | 79.4 M | 77.5 M | 60.5 M | 53.5 M | 48.3 M | 45 M | 42.8 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 127 M | 42.8 M | 85.6 M |
Quarterly Shares NeoGenomics
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 128 M | 127 M | 128 M | 127 M | 126 M | 126 M | 127 M | 126 M | 125 M | 125 M | 127 M | 124 M | 124 M | 124 M | 124 M | 123 M | 118 M | 116 M | 112 M | 110 M | 108 M | 104 M | 104 M | 104 M | 98.3 M | 94.7 M | 93.3 M | 87.3 M | 81 M | 80.5 M | 86.7 M | 79.6 M | 79.4 M | 78.6 M | 78.5 M | 78.1 M | 77.4 M | 76.1 M | 60.9 M | 60.5 M | 60.4 M | 60.3 M | 60 M | 54.4 M | 49.9 M | 49.3 M | 49 M | 48.9 M | 48.8 M | 46.3 M | 45.3 M | 45.2 M | 45 M | 44.7 M | 43.1 M | 43.1 M | 42.9 M | 41.7 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 128 M | 41.7 M | 87.2 M |
Shares of other stocks in the Diagnostics research industry
| Issuer | Shares | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
20.9 M | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
89.5 M | - | -17.87 % | $ 25.9 M | ||
|
Brainsway Ltd.
BWAY
|
31.2 M | $ 22.03 | 3.19 % | $ 99.4 M | ||
|
Accelerate Diagnostics
AXDX
|
82.2 M | - | -61.36 % | $ 2.46 M | ||
|
Burning Rock Biotech Limited
BNR
|
82.1 M | $ 22.9 | 19.89 % | $ 246 M | ||
|
Biocept
BIOC
|
17 M | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
32.3 M | - | 0.22 % | $ 16.8 M | ||
|
BioNano Genomics
BNGO
|
1.27 M | $ 1.6 | -0.62 % | $ 2.03 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
26.6 M | - | - | $ 562 M | ||
|
Co-Diagnostics
CODX
|
29.3 M | $ 6.05 | 6.14 % | $ 178 M | ||
|
Castle Biosciences
CSTL
|
27.8 M | $ 40.8 | 1.83 % | $ 1.13 B | ||
|
DermTech
DMTK
|
32.6 M | - | -11.32 % | $ 2.94 M | ||
|
Danaher Corporation
DHR
|
731 M | $ 234.89 | -0.73 % | $ 172 B | ||
|
DarioHealth Corp.
DRIO
|
28.4 M | $ 12.11 | -10.18 % | $ 344 M | ||
|
Global Cord Blood Corporation
CO
|
122 M | - | - | $ 399 M | ||
|
DexCom
DXCM
|
386 M | $ 70.15 | 0.37 % | $ 27.1 B | ||
|
Fluidigm Corporation
FLDM
|
74.3 M | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
9.22 B | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
461 M | - | 0.12 % | $ 80.1 M | ||
|
Enzo Biochem
ENZ
|
50.9 K | - | -8.98 % | $ 14.8 K | ||
|
PRA Health Sciences, Inc.
PRAH
|
63.8 M | - | - | $ 10.7 B | ||
|
Exact Sciences Corporation
EXAS
|
185 M | $ 101.62 | -0.03 % | $ 18.8 B | ||
|
CareDx, Inc
CDNA
|
53.8 M | $ 18.99 | 0.96 % | $ 1.02 B | ||
|
Fulgent Genetics
FLGT
|
30.2 M | $ 27.97 | 7.62 % | $ 846 M | ||
|
Celcuity
CELC
|
39.4 M | $ 109.72 | 4.47 % | $ 4.33 B | ||
|
Anixa Biosciences
ANIX
|
31.9 K | $ 3.26 | 2.4 % | $ 104 K | ||
|
Guardant Health
GH
|
123 M | $ 110.12 | -1.97 % | $ 13.5 B | ||
|
Koninklijke Philips N.V.
PHG
|
904 M | $ 29.05 | 1.22 % | $ 20 B | ||
|
Aspira Women's Health
AWH
|
117 M | - | -6.19 % | $ 10.5 M | ||
|
Heska Corporation
HSKA
|
10.3 M | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
889 K | - | -20.0 % | $ 1.06 M | ||
|
IQVIA Holdings
IQV
|
181 M | $ 244.09 | 1.5 % | $ 44.3 B | ||
|
Illumina
ILMN
|
159 M | $ 151.07 | 2.65 % | $ 24 B | ||
|
Charles River Laboratories International
CRL
|
51.4 M | $ 216.28 | - | $ 11.1 B | ||
|
Quest Diagnostics Incorporated
DGX
|
111 M | $ 178.22 | -1.22 % | $ 19.8 B | ||
|
Biodesix
BDSX
|
130 M | $ 5.86 | -2.82 % | $ 760 M | ||
|
Laboratory Corporation of America Holdings
LH
|
83.9 M | $ 253.83 | -2.49 % | $ 21.3 B | ||
|
Motus GI Holdings
MOTS
|
1.55 M | - | -34.28 % | $ 263 K | ||
|
ICON Public Limited Company
ICLR
|
82.5 M | $ 202.64 | 0.58 % | $ 16.7 B | ||
|
IDEXX Laboratories
IDXX
|
82.5 M | $ 710.27 | 0.49 % | $ 58.6 B | ||
|
Lantheus Holdings
LNTH
|
69.2 M | $ 69.22 | -0.66 % | $ 4.79 B | ||
|
Agilent Technologies
A
|
304 M | $ 147.47 | -0.1 % | $ 44.8 B | ||
|
Biomerica
BMRA
|
2.3 M | $ 2.78 | 5.41 % | $ 6.39 M | ||
|
Bioventus
BVS
|
62.6 M | $ 7.56 | -1.18 % | $ 474 M | ||
|
Check-Cap Ltd.
CHEK
|
5.85 M | - | - | $ 9.42 M | ||
|
QIAGEN N.V.
QGEN
|
223 M | $ 47.23 | 0.32 % | $ 10.5 B | ||
|
Mettler-Toledo International
MTD
|
21.2 M | $ 1 462.87 | -1.54 % | $ 31 B | ||
|
Myriad Genetics
MYGN
|
90.6 M | $ 6.7 | 2.68 % | $ 607 M | ||
|
ENDRA Life Sciences
NDRA
|
537 K | $ 4.51 | -1.96 % | $ 2.42 M |